Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
RadNet, Inc. (RDNT)
USD62.53
-0.78 (-1.23%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
1508, 1510 and 1516 Cotner Avenue 90025-3303
Los Angeles, CA, US
Los Angeles, CA, US
CEO
Howard G. Berger
Website
radnet.com
IPO
1997-01-03
CIK 790526 ISIN US7504911022
Description
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD62.53
-0.78 (-1.23%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
874.8K
Beta
1.39
Float Shares
69.92M
Free Float %
89.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.18% | -4.66% | +1.03% | -14.16% | -24.78% | -21.51% | -1.81% | +107.56% | +142.95% | +1,004.54% | +7,467.57% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
62.53
Low
90.00
+43.9%
Consensus
92.00
+47.1%
Median
92.00
+47.1%
High
95.00
+51.9%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
91.00
+45.5%
|
| Last Year | 7 |
87.86
+40.5%
|
| All Time | 17 |
79.29
+26.8%
|
Quality scores
Altman Z-Score
1.66
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+11.5% ★ Q1'26: +22.1% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%-768.5% Q1'26: +15.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-0.2% Q1'26: +3.9% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+4.5% Q1'26: -2.8% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+2.2% Q1'26: -1.7% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+0.6% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×7.65× Q1'26: 16.92× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
809.63M
est: 800.14M (+1.2%)
|
884.54M
est: 888.38M (-0.4%)
|
922.19M
est: 915.10M (+0.8%)
|
975.15M
est: 966.14M (+0.9%)
|
1.15B
est: 1.15B (+0.6%)
|
1.07B
est: 1.06B (+0.7%)
|
1.32B
est: 1.33B (-1.1%)
|
1.43B
est: 1.39B (+2.6%)
|
1.62B
est: 1.71B (-5.7%)
|
1.83B
est: 1.81B (+0.8%)
|
2.04B
est: 2.01B (+1.6%)
|
2.48B
2.44B – 2.51B
+23.5% YoY
|
2.75B
2.68B – 2.82B
+10.7% YoY
|
3.03B
3.02B – 3.04B
+10.3% YoY
|
| EBITDA |
116.94M
est: 146.81M (-20.3%)
|
108.73M
est: 163.00M (-33.3%)
|
119.81M
est: 167.90M (-28.6%)
|
107.60M
est: 177.27M (-39.3%)
|
225.16M
est: 210.54M (+6.9%)
|
199.74M
est: 195.33M (+2.3%)
|
278.37M
est: 244.06M (+14.1%)
|
278.53M
est: 255.67M (+8.9%)
|
292.79M
est: 291.38M (+0.5%)
|
262.55M
est: 308.49M (-14.9%)
|
242.93M
est: 341.59M (-28.9%)
|
421.83M
415.03M – 426.94M
+23.5% YoY
|
467.12M
455.44M – 478.80M
+10.7% YoY
|
515.43M
513.92M – 516.94M
+10.3% YoY
|
| EBIT |
56.33M
est: 51.46M (+9.5%)
|
42.12M
est: 57.13M (-26.3%)
|
53.01M
est: 58.85M (-9.9%)
|
34.70M
est: 62.14M (-44.2%)
|
77.71M
est: 73.80M (+5.3%)
|
45.03M
est: 68.47M (-34.2%)
|
107.71M
est: 85.55M (+25.9%)
|
93.81M
est: 89.62M (+4.7%)
|
103.29M
est: 111.07M (-7.0%)
|
124.71M
est: 117.59M (+6.1%)
|
90.80M
est: 130.21M (-30.3%)
|
160.80M
158.21M – 162.75M
+23.5% YoY
|
178.06M
173.61M – 182.52M
+10.7% YoY
|
196.48M
195.90M – 197.05M
+10.3% YoY
|
| Net Income |
7.71M
est: 22.80M (-66.2%)
|
7.23M
est: 15.33M (-52.8%)
|
53.0K
est: 20.19M (-99.7%)
|
32.24M
est: 18.44M (+74.8%)
|
14.76M
est: 19.44M (-24.1%)
|
-14.84M
est: -16.45M (+9.8%)
|
24.73M
est: 53.27M (-53.6%)
|
10.65M
est: 19.30M (-44.8%)
|
3.04M
est: 10.61M (-71.3%)
|
2.79M
est: 36.72M (-92.4%)
|
-18.65M
est: 26.78M (-169.6%)
|
46.35M
24.87M – 67.83M
+73.1% YoY
|
65.82M
62.37M – 94.28M
+42.0% YoY
|
94.93M
90.68M – 99.18M
+44.2% YoY
|
| SGA |
745.0K
|
2.88M
|
1.82M
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
0.18
est: 0.31 (-41.0%)
|
0.16
est: 0.21 (-22.0%)
|
0.00
est: 0.27 (-99.6%)
|
0.67
est: 0.25 (+171.6%)
|
0.47
est: 0.26 (+80.8%)
|
-0.29
est: -0.22 (-31.8%)
|
0.47
est: 0.71 (-34.0%)
|
0.19
est: 0.26 (-26.9%)
|
0.05
est: 0.14 (-66.3%)
|
0.04
est: 0.49 (-92.2%)
|
-0.25
est: 0.38 (-166.3%)
|
0.62
0.33 – 0.90
+64.8% YoY
|
1.04
0.83 – 1.25
+67.6% YoY
|
1.26
1.21 – 1.32
+21.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-21 | Barclays | Overweight | Overweight | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
100.21M
OE per share TTM
1.32
Owner's Yield
2.33%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
90.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
149
Total invested
1.06B
Insider transactions (90d)
1
Beneficial owners (>5%)
26
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 6.41M | 12.00% | 6.36M | — | 6.41M | — | HC | Delaware | 2022-01-27 | ↗ |
| 2 | Trust | 6.23M | 14.08% | 6.23M | — | 6.23M | — | OO | United States | 2015-07-10 | ↗ |
| 3 | Howard G. Berger | 5.40M | 12.70% | — | 5.40M | — | 10.00 | IN | United States | 2015-02-17 | ↗ |
| 4 | Trust II (formerly HFB Heirs’ Family Trust) | 5.38M | 11.37% | 5.38M | — | 5.38M | — | OO | United States | 2017-10-06 | ↗ |
| 5 | (. 13-0477010 | 3.22M | 11.00% | 3.22M | — | 3.22M | — | IA | New York | 2023-02-08 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 3.15M | 5.89% | — | 86.4K | 3.02M | 122.9K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 7 | 20-4117349 | 2.65M | 6.60% | 2.65M | — | 2.65M | 10.00 | PN | Delaware | 2013-05-10 | ↗ |
| 8 | 73-1726370 | 2.65M | 6.60% | 2.65M | — | 2.65M | 10.00 | OO | Delaware | 2013-05-10 | ↗ |
| 9 | Inc. 13-4057186 | 2.65M | 6.60% | 2.65M | — | 2.65M | 10.00 | CO | Delaware | 2013-05-10 | ↗ |
| 10 | Willem Mesdag | 2.65M | 6.60% | 2.65M | — | 2.65M | 10.00 | IN | U.S. Citizen | 2013-05-10 | ↗ |
| 11 | MICHAEL M. ROTHENBERG | 2.48M | 5.20% | — | — | 2.48M | — | HC, IN | DELAWARE | 2018-02-22 | ↗ |
| 12 | Alan Weber | 2.44M | 6.10% | — | — | — | — | HC, IN | Citizenship or Place of Organization | 2013-06-04 | ↗ |
| 13 | of 8 Pages | 2.36M | 5.90% | — | 2.36M | — | 2.36M | OO | Delaware, United States of America | 2013-11-14 | ↗ |
| 14 | MOAB CAPITAL PARTNERS, LLC | 2.32M | 4.90% | — | — | 2.32M | — | IA | DELAWARE | 2018-02-22 | ↗ |
| 15 | MOAB PARTNERS, L.P. | 2.32M | 4.90% | — | — | 2.32M | — | PN | DELAWARE | 2018-02-22 | ↗ |
| 16 | JB Capital Partners LP | 2.00M | 5.00% | — | — | — | — | PN | Citizenship or Place of Organization | 2013-06-04 | ↗ |
| 17 | Richard Mashaal | 1.80M | 3.77% | — | 1.80M | — | — | HC, IN | Delaware | 2018-02-12 | ↗ |
| 18 | Senvest Management, LLC | 1.80M | 3.77% | — | 1.80M | — | — | IA, OO | Delaware | 2018-02-12 | ↗ |
| 19 | MOAB PI GP, LLC | 157.2K | 1.00% | — | — | 157.2K | — | OO | DELAWARE | 2018-02-22 | ↗ |
| 20 | MOAB PRIVATE INVESTMENTS, LP | 157.2K | 1.00% | — | — | 157.2K | — | PN | DELAWARE | 2018-02-22 | ↗ |
| 21 | of 7 Pages | 898.00 | 0.00% | — | 898.00 | — | 898.00 | OO | Delaware, United States of America | 2014-01-30 | ↗ |
| 22 | Fran Berger | — | 0.00% | — | — | — | 10.00 | IN | United States | 2016-01-20 | ↗ |
| 23 | HFB Enterprises, LLC | — | 0.00% | — | — | — | 10.00 | OO | Nevada | 2016-01-20 | ↗ |
| 24 | Howard G. Berger, M.D. | — | 0.00% | — | — | — | 10.00 | IN | United States | 2016-01-20 | ↗ |
| 25 | Howard and Fran Berger Family Trust | — | 0.00% | — | — | — | 10.00 | OO | United States | 2016-01-20 | ↗ |
| 26 | Moab Private Investments, L.P. | — | 0.00% | — | — | — | — | IA, PN | Delaware | 2020-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
149
-204 vs prev Q
New positions
25
Closed positions
219
Increased
73
Reduced
43
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 10.02M +567.3K (+6.0%) | 715.00M -5.5M (-0.8%) | 13.41% +0.651 pp | 0.01% -0.001 pp | USD69.31 +2.9% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 7.46M -20.8K (-0.3%) | 532.49M -37.9M (-6.6%) | 9.99% -0.113 pp | 0.01% -0.001 pp | USD49.63 +43.8% | 76 qtrs — |
| 3 | RTW INVESTMENTS, LP | 3.94M +1.1M (+39.9%) | 281.01M +66.4M (+31.0%) | 5.27% +1.471 pp | 2.81% +0.171 pp | USD55.75 +28.0% | 9 qtrs — |
| 4 | BECK MACK & OLIVER LLC | 3.23M -45.3K (-1.4%) | 230.56M -19.2M (-7.7%) | 4.33% -0.098 pp | 4.19% -0.354 pp | USD19.80 +260.4% | 43 qtrs — |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.70M +627.9K (+30.3%) | 192.58M +34.7M (+22.0%) | 3.61% +0.817 pp | 0.02% +0.004 pp | USD73.98 -3.6% | 70 qtrs — |
| 6 | STATE STREET CORP | 2.58M +41.4K (+1.6%) | 184.02M -9.4M (-4.9%) | 3.45% +0.026 pp | 0.01% -0.001 pp | USD25.72 +177.4% | 51 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.67M +6.7K (+0.4%) | 119.28M -7.6M (-6.0%) | 2.24% -0.010 pp | 0.01% -0.001 pp | USD26.98 +164.5% | 74 qtrs — |
| 8 | INVESCO LTD. | 1.60M +333.9K (+26.4%) | 113.93M +17.7M (+18.4%) | 2.14% +0.433 pp | 0.02% +0.002 pp | USD42.57 +67.6% | 57 qtrs — |
| 9 | JB CAPITAL PARTNERS LP | 1.42M +— (+0.0%) | 101.61M -6.9M (-6.4%) | 1.91% -0.016 pp | 17.48% -0.886 pp | USD28.35 +151.7% | 20 qtrs — |
| 10 | HOOD RIVER CAPITAL MANAGEMENT LLC | 1.40M +24.6K (+1.8%) | 99.60M -4.9M (-4.7%) | 1.87% +0.017 pp | 1.09% -0.142 pp | USD41.12 +73.5% | 11 qtrs — |
| 11 | DIMENSIONAL FUND ADVISORS LP | 1.36M -17.9K (-1.3%) | 97.02M -8.0M (-7.6%) | 1.82% -0.040 pp | 0.02% -0.002 pp | USD10.84 +558.2% | 51 qtrs — |
| 12 | ALYESKA INVESTMENT GROUP, L.P. | 1.15M +— (+0.0%) | 82.22M -5.6M (-6.4%) | 1.54% -0.013 pp | 0.23% -0.034 pp | USD57.09 +25.0% | 11 qtrs — |
| 13 | PRINCIPAL FINANCIAL GROUP INC | 1.13M -8.7K (-0.8%) | 80.85M -6.2M (-7.1%) | 1.52% -0.025 pp | 0.04% -0.003 pp | USD34.52 +106.7% | 25 qtrs — |
| 14 | AMERIPRISE FINANCIAL INC | 1.12M -293.6K (-20.8%) | 79.92M -27.8M (-25.8%) | 1.50% -0.409 pp | 0.02% -0.007 pp | USD48.74 +46.4% | 25 qtrs — |
| 15 | CLEARBRIDGE INVESTMENTS, LLC | 1.11M -71.1K (-6.0%) | 79.55M -10.8M (-12.0%) | 1.49% -0.109 pp | 0.06% -0.004 pp | USD53.87 +32.4% | 8 qtrs — |
| 16 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 1.05M -694.8K (-39.9%) | 74.38M -61.6M (-45.3%) | 1.40% -0.950 pp | 0.12% -0.098 pp | USD53.50 +33.4% | 17 qtrs — |
| 17 | MORGAN STANLEY | 950.0K +218.1K (+29.8%) | 67.78M +12.0M (+21.5%) | 1.27% +0.284 pp | 0.00% +0.001 pp | USD47.72 +49.5% | 51 qtrs — |
| 18 | AMERICAN CENTURY COMPANIES INC | 908.0K -355.5K (-28.1%) | 64.79M -31.5M (-32.7%) | 1.22% -0.490 pp | 0.03% -0.016 pp | USD46.58 +53.2% | 23 qtrs — |
| 19 | VAN BERKOM & ASSOCIATES INC. | 823.7K +146.0 (+0.0%) | 58.77M -4.0M (-6.4%) | 1.10% -0.009 pp | 1.69% -0.121 pp | USD76.07 -6.2% | 3 qtrs — |
| 20 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 822.7K -249.1K (-23.2%) | 58.70M -23.0M (-28.1%) | 1.10% -0.346 pp | 0.04% -0.013 pp | USD54.13 +31.8% | 8 qtrs — |
| 21 | BAMCO INC /NY/ | 810.1K +— (+0.0%) | 57.80M -3.9M (-6.4%) | 1.08% -0.009 pp | 0.16% -0.007 pp | USD50.73 +40.6% | 8 qtrs — |
| 22 | FULLER & THALER ASSET MANAGEMENT, INC. | 768.5K +62.8K (+8.9%) | 54.83M +1.1M (+2.0%) | 1.03% +0.076 pp | 0.19% +0.002 pp | USD75.81 -5.9% | 2 qtrs — |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 758.3K +17.3K (+2.3%) | 54.10M -2.4M (-4.2%) | 1.02% +0.015 pp | 0.01% -0.001 pp | USD31.12 +129.3% | 47 qtrs — |
| 24 | LOOMIS SAYLES & CO L P | 743.5K -34.7K (-4.5%) | 53.05M -6.3M (-10.6%) | 1.00% -0.055 pp | 0.06% -0.007 pp | USD34.22 +108.5% | 10 qtrs — |
| 25 | NORTHERN TRUST CORP | 729.5K -26.9K (-3.6%) | 52.05M -5.6M (-9.7%) | 0.98% -0.045 pp | 0.01% -0.001 pp | USD24.69 +189.0% | 51 qtrs — |
| 26 | NUVEEN, LLC | 698.4K +161.9K (+30.2%) | 49.83M +8.9M (+21.9%) | 0.93% +0.211 pp | 0.01% +0.002 pp | USD54.73 +30.4% | 4 qtrs — |
| 27 | UBS ASSET MANAGEMENT AMERICAS INC | 689.2K +153.0K (+28.5%) | 49.18M +8.3M (+20.3%) | 0.92% +0.199 pp | 0.01% +0.002 pp | USD48.45 +47.3% | 32 qtrs — |
| 28 | POLAR CAPITAL HOLDINGS PLC | 658.1K -174.2K (-20.9%) | 46.95M -16.5M (-26.0%) | 0.88% -0.243 pp | 0.18% -0.124 pp | USD76.21 -6.4% | 2 qtrs — |
| 29 | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 651.2K +1.8K (+0.3%) | 46.46M -3.0M (-6.1%) | 0.87% -0.005 pp | 2.71% -0.156 pp | USD20.85 +242.2% | 26 qtrs — |
| 30 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 632.3K -244.8K (-27.9%) | 45.11M -21.7M (-32.5%) | 0.85% -0.338 pp | 0.08% -0.050 pp | USD51.92 +37.4% | 22 qtrs — |
| 31 | NEUBERGER BERMAN GROUP LLC | 589.0K +132.1K (+28.9%) | 42.02M +7.2M (+20.7%) | 0.79% +0.172 pp | 0.03% +0.006 pp | USD59.42 +20.1% | 10 qtrs — |
| 32 | GOLDMAN SACHS GROUP INC | 583.0K +583.0K (+100.0%) | 41.60M +41.6M (+100.0%) | 0.78% +0.780 pp | 0.01% +0.005 pp | USD71.35 +0.0% | 1 qtrs NEW |
| 33 | SOROS FUND MANAGEMENT LLC | 574.6K +396.1K (+221.9%) | 40.99M +27.4M (+201.4%) | 0.77% +0.528 pp | 0.48% +0.281 pp | USD72.86 -2.1% | 2 qtrs — |
| 34 | FRANKLIN RESOURCES INC | 556.3K -691.0 (-0.1%) | 39.70M -2.8M (-6.5%) | 0.74% -0.007 pp | 0.01% -0.001 pp | USD58.43 +22.1% | 11 qtrs — |
| 35 | FRED ALGER MANAGEMENT, LLC | 547.9K +57.6K (+11.7%) | 39.09M +1.7M (+4.6%) | 0.73% +0.072 pp | 0.15% +0.008 pp | USD63.68 +12.0% | 5 qtrs — |
| 36 | ALPHA WAVE GLOBAL, LP | 541.5K +8.2K (+1.5%) | 38.63M -2.0M (-4.9%) | 0.72% +0.005 pp | 4.74% +0.620 pp | USD54.43 +31.1% | 9 qtrs — |
| 37 | WESTFIELD CAPITAL MANAGEMENT CO LP | 531.8K +5.9K (+1.1%) | 37.94M -2.1M (-5.3%) | 0.71% +0.002 pp | 0.16% -0.010 pp | USD76.16 -6.3% | 2 qtrs — |
| 38 | — | 517.8K +517.8K (+100.0%) | 37.02M +37.0M (+100.0%) | 0.69% +0.693 pp | 1.21% +1.212 pp | USD71.35 +0.0% | 1 qtrs NEW |
| 39 | PENSERRA CAPITAL MANAGEMENT LLC | 517.8K +38.7K (+8.1%) | 36.95M +436.0K (+1.2%) | 0.69% +0.046 pp | 0.44% +0.002 pp | USD64.69 +10.3% | 7 qtrs — |
| 40 | BANK OF AMERICA CORP /DE/ | 512.4K +136.4K (+36.3%) | 36.56M +7.9M (+27.6%) | 0.69% +0.178 pp | 0.00% +0.001 pp | USD50.30 +41.8% | 52 qtrs — |
| 41 | BESSEMER GROUP INC | 494.0K +50.7K (+11.4%) | 35.25M +1.5M (+4.3%) | 0.66% +0.063 pp | 0.05% +0.003 pp | USD50.02 +42.6% | 13 qtrs — |
| 42 | GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 488.2K -214.6K (-30.5%) | 34.83M -18.7M (-35.0%) | 0.65% -0.295 pp | 2.12% -0.936 pp | USD34.43 +107.2% | 29 qtrs — |
| 43 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 476.6K +247.4K (+107.9%) | 34.01M +16.5M (+94.6%) | 0.64% +0.329 pp | 0.05% +0.024 pp | USD60.26 +18.4% | 11 qtrs — |
| 44 | DEUTSCHE BANK AG\ | 476.1K -10.3K (-2.1%) | 33.97M -3.1M (-8.4%) | 0.64% -0.019 pp | 0.01% -0.001 pp | USD23.55 +203.0% | 50 qtrs — |
| 45 | ROYAL BANK OF CANADA | 474.4K -15.8K (-3.2%) | 33.85M -3.5M (-9.4%) | 0.64% -0.027 pp | 0.01% -0.001 pp | USD50.72 +40.7% | 51 qtrs — |
| 46 | NORGES BANK | 450.7K +450.7K (+100.0%) | 32.16M +32.2M (+100.0%) | 0.60% +0.603 pp | 0.00% +0.003 pp | USD71.35 +0.0% | 1 qtrs NEW |
| 47 | BANK OF NEW YORK MELLON CORP | 422.8K -3.6K (-0.8%) | 30.17M -2.3M (-7.2%) | 0.57% -0.010 pp | 0.01% -0.001 pp | USD28.27 +152.4% | 66 qtrs — |
| 48 | WELLINGTON MANAGEMENT GROUP LLP | 405.8K -58.4K (-12.6%) | 28.96M -6.4M (-18.1%) | 0.54% -0.083 pp | 0.01% -0.001 pp | USD37.66 +89.5% | 10 qtrs — |
| 49 | TOROSO INVESTMENTS, LLC | 400.2K -33.4K (-7.7%) | 28.55M -4.5M (-13.6%) | 0.54% -0.050 pp | 0.07% +0.002 pp | USD64.49 +10.6% | 7 qtrs — |
| 50 | EMERALD ADVISERS, LLC | 394.7K -247.5K (-38.5%) | 28.16M -20.8M (-42.5%) | 0.53% -0.339 pp | 0.87% -0.701 pp | USD34.94 +104.2% | 10 qtrs — |
| 51 | RAYMOND JAMES FINANCIAL INC | 393.5K -41.3K (-9.5%) | 28.10M -5.0M (-15.2%) | 0.53% -0.060 pp | 0.01% -0.002 pp | USD68.87 +3.6% | 5 qtrs — |
| 52 | MILLENNIUM MANAGEMENT LLC | 381.0K +361.8K (+1,884.3%) | 27.18M +25.7M (+1,757.7%) | 0.51% +0.484 pp | 0.01% +0.011 pp | USD70.14 +1.7% | 22 qtrs — |
| 53 | JENNISON ASSOCIATES LLC | 350.6K -9.6K (-2.7%) | 25.02M -2.4M (-8.9%) | 0.47% -0.017 pp | 0.02% -0.001 pp | USD60.68 +17.6% | 6 qtrs — |
| 54 | VOYA INVESTMENT MANAGEMENT LLC | 340.8K -149.6K (-30.5%) | 24.32M -13.1M (-34.9%) | 0.46% -0.206 pp | 0.02% -0.013 pp | USD55.35 +28.9% | 47 qtrs — |
| 55 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 335.3K -216.0K (-39.2%) | 23.92M -18.1M (-43.1%) | 0.45% -0.296 pp | 0.16% -0.114 pp | USD30.24 +135.9% | 26 qtrs — |
| 56 | SEGALL BRYANT & HAMILL, LLC | 317.5K -51.5K (-13.9%) | 22.65M -5.5M (-19.4%) | 0.43% -0.073 pp | 0.31% -0.068 pp | USD61.91 +15.2% | 7 qtrs — |
| 57 | UBS GROUP AG | 315.4K -31.3K (-9.0%) | 22.51M -3.9M (-14.8%) | 0.42% -0.046 pp | 0.00% -0.001 pp | USD63.82 +11.8% | 45 qtrs — |
| 58 | PICTON MAHONEY ASSET MANAGEMENT | 300.0K +300.0K (+100.0%) | 21.41M +21.4M (+100.0%) | 0.40% +0.402 pp | 0.17% +0.166 pp | USD71.35 +0.0% | 1 qtrs NEW |
| 59 | PENN CAPITAL MANAGEMENT COMPANY, LLC | 274.4K -8.5K (-3.0%) | 19.62M -2.0M (-9.2%) | 0.37% -0.015 pp | 1.56% -0.097 pp | USD42.00 +69.9% | 11 qtrs — |
| 60 | SEI INVESTMENTS CO | 269.3K +3.6K (+1.4%) | 19.21M -1.0M (-5.1%) | 0.36% +0.002 pp | 0.02% -0.003 pp | USD56.79 +25.6% | 11 qtrs — |
| 61 | WCM INVESTMENT MANAGEMENT, LLC | 268.2K -17.6K (-6.1%) | 19.18M -2.2M (-10.2%) | 0.36% -0.027 pp | 0.04% -0.005 pp | USD70.58 +1.1% | 5 qtrs — |
| 62 | POINT72 ASSET MANAGEMENT, L.P. | 257.6K +257.6K (+100.0%) | 18.38M +18.4M (+100.0%) | 0.34% +0.345 pp | 0.02% +0.021 pp | USD71.35 +0.0% | 4 qtrs — |
| 63 | EMERALD MUTUAL FUND ADVISERS TRUST | 251.2K -121.5K (-32.6%) | 17.93M -10.5M (-36.9%) | 0.34% -0.167 pp | 0.87% -0.594 pp | USD32.29 +121.0% | 10 qtrs — |
| 64 | NEW YORK STATE COMMON RETIREMENT FUND | 247.7K +240.0 (+0.1%) | 17.67M -1.2M (-6.3%) | 0.33% -0.003 pp | 0.02% -0.001 pp | USD42.47 +68.0% | 45 qtrs — |
| 65 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 240.3K -29.7K (-11.0%) | 17.14M -3.4M (-16.7%) | 0.32% -0.043 pp | 0.06% -0.018 pp | USD46.74 +52.7% | 25 qtrs — |
| 66 | WHITTIER TRUST CO | 219.3K +452.0 (+0.2%) | 16.96M -26.3K (-0.2%) | 0.29% -0.002 pp | 0.18% -0.010 pp | USD59.64 +19.6% | 7 qtrs — |
| 67 | FMR LLC | 221.9K +214.4K (+2,856.5%) | 15.84M +15.3M (+2,668.0%) | 0.30% +0.287 pp | 0.00% +0.001 pp | USD70.76 +0.8% | 31 qtrs — |
| 68 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 200.0K -100.0K (-33.3%) | 14.27M -8.6M (-37.6%) | 0.27% -0.137 pp | 0.71% -0.838 pp | USD52.42 +36.1% | 4 qtrs — |
| 69 | JANE STREET GROUP, LLC | 196.0K +97.3K (+98.6%) | 13.98M +6.5M (+85.9%) | 0.26% +0.129 pp | 0.00% +0.001 pp | USD65.35 +9.2% | 16 qtrs — |
| 70 | BALYASNY ASSET MANAGEMENT L.P. | 194.2K +161.5K (+493.4%) | 13.86M +11.4M (+455.6%) | 0.26% +0.216 pp | 0.02% +0.014 pp | USD72.17 -1.1% | 2 qtrs — |
| 71 | ROBOTTI ROBERT | 184.1K -2.1K (-1.1%) | 13.13M -1.1M (-7.4%) | 0.25% -0.005 pp | 2.36% -0.103 pp | USD7.76 +819.5% | 42 qtrs — |
| 72 | RHUMBLINE ADVISERS | 182.1K -5.9K (-3.2%) | 12.99M -1.3M (-9.3%) | 0.24% -0.010 pp | 0.01% -0.001 pp | USD24.70 +188.9% | 47 qtrs — |
| 73 | FREESTONE GROVE PARTNERS LP | 181.0K -88.3K (-32.8%) | 12.92M -7.6M (-37.1%) | 0.24% -0.121 pp | 0.09% -0.060 pp | USD76.21 -6.4% | 4 qtrs — |
| 74 | LEGAL & GENERAL GROUP PLC | 171.1K -7.8K (-4.3%) | 12.21M -1.4M (-10.4%) | 0.23% -0.012 pp | 0.00% 0.000 pp | USD26.45 +169.8% | 44 qtrs — |
| 75 | ALLIANCEBERNSTEIN L.P. | 164.4K +45.4K (+38.2%) | 11.73M +2.7M (+29.4%) | 0.22% +0.060 pp | 0.00% +0.001 pp | USD50.19 +42.2% | 47 qtrs — |
| 76 | PALISADE CAPITAL MANAGEMENT, LP | 161.1K -18.8K (-10.5%) | 11.50M -2.2M (-16.2%) | 0.22% -0.027 pp | 0.34% -0.032 pp | USD53.74 +32.8% | 4 qtrs — |
| 77 | AGF MANAGEMENT LTD | 159.0K -7.1K (-4.3%) | 11.35M -1.3M (-10.4%) | 0.21% -0.011 pp | 0.05% -0.007 pp | USD65.39 +9.1% | 7 qtrs — |
| 78 | CERITY PARTNERS LLC | 147.4K +687.0 (+0.5%) | 10.52M -663.9K (-5.9%) | 0.20% -0.001 pp | 0.02% -0.003 pp | USD57.82 +23.4% | 12 qtrs — |
| 79 | SWISS NATIONAL BANK | 129.0K +2.4K (+1.9%) | 9.20M -444.0K (-4.6%) | 0.17% +0.002 pp | 0.01% 0.000 pp | USD24.02 +197.0% | 33 qtrs — |
| 80 | WHITTIER TRUST CO OF NEVADA INC | 116.9K +1.8K (+1.5%) | 9.04M +103.4K (+1.2%) | 0.16% +0.001 pp | 0.19% -0.003 pp | USD59.41 +20.1% | 7 qtrs — |
| 81 | PIER CAPITAL, LLC | 121.0K -1.0K (-0.9%) | 8.63M -667.4K (-7.2%) | 0.16% -0.003 pp | 1.38% -0.076 pp | USD36.49 +95.5% | 19 qtrs — |
| 82 | PORTOLAN CAPITAL MANAGEMENT, LLC | 117.5K -109.2K (-48.2%) | 8.38M -8.9M (-51.5%) | 0.16% -0.149 pp | 0.45% -0.486 pp | USD60.78 +17.4% | 11 qtrs — |
| 83 | CITIGROUP INC | 116.9K +9.7K (+9.0%) | 8.34M +169.0K (+2.1%) | 0.16% +0.012 pp | 0.00% +0.000 pp | USD44.78 +59.3% | 47 qtrs — |
| 84 | BNP PARIBAS ARBITRAGE, SNC | 116.5K +101.3K (+668.4%) | 8.31M +7.2M (+619.4%) | 0.16% +0.136 pp | 0.00% +0.003 pp | USD70.63 +1.0% | 49 qtrs — |
| 85 | HARBOR CAPITAL ADVISORS, INC. | 113.8K -10.6K (-8.5%) | 8.12M -1.4M (-14.4%) | 0.15% -0.016 pp | 0.63% -0.106 pp | USD63.07 +13.1% | 8 qtrs — |
| 86 | SEQUOIA FINANCIAL ADVISORS, LLC | 113.7K +709.0 (+0.6%) | 8.11M -498.4K (-5.8%) | 0.15% 0.000 pp | 0.05% -0.007 pp | USD49.91 +43.0% | 4 qtrs — |
| 87 | ROYCE & ASSOCIATES LP | 113.7K -11.2K (-9.0%) | 8.11M -1.4M (-14.8%) | 0.15% -0.016 pp | 0.08% -0.013 pp | USD25.62 +178.5% | 36 qtrs — |
| 88 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 110.0K +110.0K (+100.0%) | 7.85M +7.8M (+100.0%) | 0.15% +0.147 pp | 0.93% +0.933 pp | USD71.35 +0.0% | 4 qtrs — |
| 89 | WELLS FARGO & COMPANY/MN | 109.7K +34.7K (+46.3%) | 7.83M +2.1M (+37.0%) | 0.15% +0.046 pp | 0.00% +0.000 pp | USD53.75 +32.7% | 57 qtrs — |
| 90 | ENVESTNET ASSET MANAGEMENT INC | 107.6K -21.0K (-16.4%) | 7.67M -2.1M (-21.7%) | 0.14% -0.030 pp | 0.00% -0.001 pp | USD43.79 +62.9% | 10 qtrs — |
| 91 | BARCLAYS PLC | 106.5K -10.5K (-9.0%) | 7.60M -518.5K (-6.4%) | 0.14% -0.015 pp | 0.00% 0.000 pp | USD60.87 +17.2% | 51 qtrs — |
| 92 | AXIOM INVESTORS LLC /DE | 105.3K -96.6K (-47.9%) | 7.51M -7.9M (-51.2%) | 0.14% -0.132 pp | 0.07% -0.047 pp | USD72.59 -1.7% | 6 qtrs — |
| 93 | CITADEL ADVISORS LLC | 96.6K +71.9K (+291.1%) | 6.89M +5.0M (+266.2%) | 0.13% +0.096 pp | 0.00% +0.001 pp | USD68.89 +3.6% | 23 qtrs — |
| 94 | MAIRS & POWER INC | 95.6K -1.8K (-1.9%) | 6.82M -604.7K (-8.1%) | 0.13% -0.004 pp | 0.07% -0.004 pp | USD64.78 +10.1% | 3 qtrs — |
| 95 | FIRST TRUST ADVISORS LP | 93.4K +90.5K (+3,147.3%) | 6.66M +6.4M (+2,940.2%) | 0.13% +0.121 pp | 0.00% +0.005 pp | USD71.50 -0.2% | 11 qtrs — |
| 96 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 93.1K +3.6K (+4.0%) | 6.65M -178.3K (-2.6%) | 0.12% +0.004 pp | 0.01% -0.001 pp | USD52.61 +35.6% | 17 qtrs — |
| 97 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 91.8K +91.2K (+14,089.8%) | 6.55M +6.5M (+13,269.4%) | 0.12% +0.122 pp | 0.01% +0.007 pp | USD71.25 +0.1% | 3 qtrs — |
| 98 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 81.4K +60.2K (+284.0%) | 5.81M +4.2M (+259.5%) | 0.11% +0.080 pp | 0.00% +0.001 pp | USD72.62 -1.7% | 24 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.00
Neutral
Buys
1
Sells
1
Shares acquired
26.0K
Shares disposed
26.0K
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Berger Howard G | Director / Officer | M-Exempt | A | Common Stock | 25,992 | 18.64 | 484.5K | 498,405 | D | ↗ |
| 2026-03-19 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 9,554 | 61.84 | 590.8K | 1,214,369 | D | ↗ |
| 2026-03-18 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 14,200 | 62.12 | 882.1K | 1,224,723 | D | ↗ |
| 2026-03-16 | Sorensen Alma Gregory | Director / Officer | F-InKind | D | Common Stock | 5,919 | 61.72 | 365.3K | 1,238,923 | D | ↗ |
| 2026-03-10 | Sorensen Alma Gregory | Director / Officer | M-Exempt | A | Common Stock | 7,481 | 0.00 | — | 1,204,325 | D | ↗ |
| 2026-03-03 | Wesdorp Cornelis | Officer | A-Award | A | Common Stock | 20,330 | 0.00 | — | 73,825 | D | ↗ |
| 2026-03-03 | Sorensen Alma Gregory | Director / Officer | A-Award | A | Common Stock | 16,533 | 0.00 | — | 1,181,878 | D | ↗ |
| 2026-03-03 | STOLPER MARK | Officer | A-Award | A | Common Stock | 18,228 | 0.00 | — | 121,943 | D | ↗ |
| 2026-03-03 | Patel Mital | Officer | A-Award | A | Common Stock | 20,667 | 0.00 | — | 200,175 | D | ↗ |
| 2026-03-03 | Murdock Michael N | Officer | A-Award | A | Common Stock | 6,613 | 0.00 | — | 46,697 | D | ↗ |
| 2026-03-03 | Katz David Jeffrey | Officer | A-Award | A | Common Stock | 19,289 | 0.00 | — | 90,866 | D | ↗ |
| 2026-03-03 | HAMES NORMAN R | Officer | A-Award | A | Common Stock | 3,100 | 0.00 | — | 22,989 | I | ↗ |
| 2026-03-03 | Forthuber Stephen M | Officer | A-Award | A | Common Stock | 22,045 | 0.00 | — | 551,266 | D | ↗ |
| 2026-03-03 | Berger Howard G | Director / Officer | A-Award | A | Common Stock | 124,001 | 0.00 | — | 472,413 | D | ↗ |
| 2025-12-10 | STOLPER MARK | Officer | M-Exempt | A | Common Stock | 35,703 | 6.07 | 216.7K | 103,715 | D | ↗ |
| 2025-12-10 | Katz David Jeffrey | Officer | M-Exempt | A | Common Stock | 3,396 | 29.44 | 100.0K | 71,577 | D | ↗ |
| 2025-12-05 | Forthuber Stephen M | Officer | S-Sale | D | Common Stock | 1,700 | 79.77 | 135.6K | 529,221 | D | ↗ |
| 2025-12-03 | Patel Mital | Officer | G-Gift | D | Common Stock | 630 | 0.00 | — | 179,508 | D | ↗ |
| 2025-12-03 | Forthuber Stephen M | Officer | M-Exempt | A | Common Stock | 39,127 | 6.07 | 237.5K | 574,309 | D | ↗ |
| 2025-11-25 | Levitt Lawrence L | Director | G-Gift | D | Common Stock | 2,700 | 0.00 | — | 164,956 | D | ↗ |
| 2025-11-19 | Patel Mital | Officer | S-Sale | D | Common Stock | 15,080 | 80.05 | 1.21M | 180,138 | D | ↗ |
| 2025-11-19 | Berger Howard G | Director / Officer | M-Exempt | A | Common Stock | 25,992 | 18.64 | 484.5K | 348,412 | D | ↗ |
| 2025-11-18 | Patel Mital | Officer | S-Sale | D | Common Stock | 9,920 | 80.00 | 793.6K | 195,218 | D | ↗ |
| 2025-11-17 | Patel Mital | Officer | S-Sale | D | Common Stock | 25,000 | 76.06 | 1.90M | 205,138 | D | ↗ |
| 2025-11-13 | Murdock Michael N | Officer | G-Gift | D | Common Stock | 3,000 | 0.00 | — | 40,084 | D | ↗ |
| 2025-09-16 | STOLPER MARK | Officer | S-Sale | D | Common Stock | 35,000 | 73.89 | 2.59M | 68,012 | D | ↗ |
| 2025-09-16 | Katz David Jeffrey | Officer | S-Sale | D | Common Stock | 14,000 | 74.44 | 1.04M | 68,181 | D | ↗ |
| 2025-09-11 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 500 | 72.13 | 36.1K | 53,495 | D | ↗ |
| 2025-09-11 | Katz David Jeffrey | Officer | G-Gift | D | Common Stock | 4,593 | 0.00 | — | 82,181 | D | ↗ |
| 2025-09-10 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 72.74 | 727.4K | 239,183 | D | ↗ |
| 2025-09-09 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 500 | 71.99 | 36.0K | 53,995 | D | ↗ |
| 2025-08-27 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 5,000 | 71.10 | 355.5K | 19,889 | I | ↗ |
| 2025-08-19 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 1,500 | 66.98 | 100.5K | 54,495 | D | ↗ |
| 2025-08-19 | Jayanathan Ranjan | Officer | S-Sale | D | Common Stock | 65,598 | 67.50 | 4.43M | 138,198 | D | ↗ |
| 2025-08-13 | Katz David Jeffrey | Officer | S-Sale | D | Common Stock | 17,000 | 68.31 | 1.16M | 86,774 | D | ↗ |
| 2025-06-17 | Sorensen Alma Gregory | Director / Officer | G-Gift | D | Common Stock | 5,600 | 0.00 | — | 1,165,345 | D | ↗ |
| 2025-06-10 | SWARTZ DAVID L | Director | A-Award | A | Common Stock | 2,699 | 0.00 | — | 176,766 | D | ↗ |
| 2025-06-10 | SPURLOCK GREGORY E. | Director | A-Award | A | Common Stock | 2,699 | 0.00 | — | 5,290 | D | ↗ |
| 2025-06-10 | Levitt Lawrence L | Director | A-Award | A | Common Stock | 2,699 | 0.00 | — | 167,656 | D | ↗ |
| 2025-06-10 | Jacobs Laura Pastre | Director | A-Award | A | Common Stock | 2,699 | 0.00 | — | 27,007 | D | ↗ |
| 2025-06-05 | Murdock Michael N | Officer | S-Sale | D | Common Stock | 11,132 | 58.05 | 646.2K | 43,084 | D | ↗ |
| 2025-06-01 | Sorensen Alma Gregory | Director / Officer | A-Award | A | Common Stock | 10,436 | 0.00 | — | 1,170,945 | D | ↗ |
| 2025-05-23 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 55,000 | 56.48 | 3.11M | 1,160,509 | D | ↗ |
| 2025-05-22 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 45,000 | 57.06 | 2.57M | 1,215,509 | D | ↗ |
| 2025-05-16 | Levitt Lawrence L | Director | S-Sale | D | Common Stock | 5,000 | 61.09 | 305.5K | 164,957 | D | ↗ |
| 2025-05-16 | Forthuber Stephen M | Officer | S-Sale | D | Common Stock | 18,820 | 60.34 | 1.14M | 535,182 | D | ↗ |
| 2025-05-15 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 2,911 | 60.00 | 174.7K | 24,889 | I | ↗ |
| 2025-05-01 | Sorensen Alma Gregory | Director / Officer | A-Award | A | Common Stock | 10,232 | 0.00 | — | 1,260,509 | D | ↗ |
| 2025-04-04 | Patel Mital | Officer | M-Exempt | A | Common Stock | 29,762 | 6.30 | 187.5K | 230,138 | D | ↗ |
| 2025-03-19 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 2,500 | 50.31 | 125.8K | 254,459 | D | ↗ |
| 2025-03-18 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 5,000 | 48.25 | 241.3K | 256,959 | D | ↗ |
| 2025-03-17 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 5,000 | 49.79 | 249.0K | 261,959 | D | ↗ |
| 2025-03-10 | Katz David Jeffrey | Officer | M-Exempt | A | Common Stock | 15,423 | 0.00 | — | 103,774 | D | ↗ |
| 2025-03-07 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 1,000 | 50.52 | 50.5K | 55,995 | D | ↗ |
| 2025-03-07 | SWARTZ DAVID L | Director | S-Sale | D | Common Stock | 25,000 | 50.84 | 1.27M | 174,067 | D | ↗ |
| 2025-03-06 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 2,000 | 51.23 | 102.5K | 56,995 | D | ↗ |
| 2025-03-05 | Wesdorp Cornelis | Officer | S-Sale | D | Common Stock | 2,000 | 52.58 | 105.2K | 58,995 | D | ↗ |
| 2025-03-05 | HAMES NORMAN R | Officer | M-Exempt | A | Common Stock | 11,194 | 10.05 | 112.5K | 266,197 | D | ↗ |
| 2025-01-08 | Sorensen Alma Gregory | Director / Officer | A-Award | A | Common Stock | 11,072 | 0.00 | — | 1,250,277 | D | ↗ |
| 2025-01-08 | STOLPER MARK | Officer | A-Award | A | Common Stock | 22,889 | 0.00 | — | 103,012 | D | ↗ |
| 2025-01-08 | Patel Mital | Officer | A-Award | A | Common Stock | 25,951 | 0.00 | — | 227,697 | D | ↗ |
| 2025-01-08 | Murdock Michael N | Officer | A-Award | A | Common Stock | 11,072 | 0.00 | — | 54,216 | D | ↗ |
| 2025-01-08 | Katz David Jeffrey | Officer | A-Award | A | Common Stock | 24,221 | 0.00 | — | 87,130 | D | ↗ |
| 2025-01-08 | Jayanathan Ranjan | Officer | A-Award | A | Common Stock | 11,072 | 0.00 | — | 203,796 | D | ↗ |
| 2025-01-08 | HAMES NORMAN R | Officer | A-Award | A | Common Stock | 27,681 | 0.00 | — | 255,003 | D | ↗ |
| 2025-01-08 | Forthuber Stephen M | Officer | A-Award | A | Common Stock | 27,681 | 0.00 | — | 551,242 | D | ↗ |
| 2025-01-08 | BERGER HOWARD G | Director / Officer | A-Award | A | Common Stock | 124,567 | 0.00 | — | 164,803 | D | ↗ |
| 2025-01-04 | Patel Mital | Officer | M-Exempt | D | Restricted Stock Units | 1,220 | 0.00 | — | 0 | D | ↗ |
| 2025-01-04 | Katz David Jeffrey | Officer | M-Exempt | A | Common Stock | 1,221 | 0.00 | — | 88,351 | D | ↗ |
| 2025-01-04 | HAMES NORMAN R | Officer | M-Exempt | A | Common Stock | 1,380 | 0.00 | — | 254,719 | D | ↗ |
| 2025-01-04 | Forthuber Stephen M | Officer | M-Exempt | D | Restricted Stock Units | 1,380 | 0.00 | — | 0 | D | ↗ |
| 2025-01-03 | BERGER HOWARD G | Director / Officer | J-Other | D | Common Stock | 250,000 | 0.00 | — | 40,236 | D | ↗ |
| 2024-12-16 | STOLPER MARK | Officer | G-Gift | D | Common Stock | 275 | 0.00 | — | 80,123 | D | ↗ |
| 2024-12-05 | Levitt Lawrence L | Director | G-Gift | D | Common Stock | 2,700 | 0.00 | — | 169,957 | D | ↗ |
| 2024-12-02 | Murdock Michael N | Officer | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 43,144 | D | ↗ |
| 2024-11-25 | Katz David Jeffrey | Officer | S-Sale | D | Common Stock | 5,110 | 82.12 | 419.6K | 62,909 | D | ↗ |
| 2024-11-19 | Jayanathan Ranjan | Officer | S-Sale | D | Common Stock | 38,557 | 80.00 | 3.08M | 192,724 | D | ↗ |
| 2024-10-01 | Wesdorp Cornelis | Officer | A-Award | A | Common Stock | 60,995 | 0.00 | — | 60,995 | D | ↗ |
| 2024-10-01 | Katz David Jeffrey | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 10,188 | 29.44 | 299.9K | 18,952 | D | ↗ |
| 2024-09-16 | Patel Mital | Officer | G-Gift | D | Common Stock | 400 | 0.00 | — | 201,746 | — | ↗ |
| 2024-09-13 | BERGER HOWARD G | Director / Officer | G-Gift | D | Common Stock | 190,000 | 0.00 | — | 290,236 | — | ↗ |
| 2024-08-21 | Murdock Michael N | Officer | S-Sale | D | Common Stock | 1,480 | 63.48 | 94.0K | 48,144 | — | ↗ |
| 2024-08-15 | BERGER HOWARD G | Director / Officer | G-Gift | D | Common Stock | 60,000 | 0.00 | — | 480,236 | — | ↗ |
| 2024-08-14 | Katz David Jeffrey | Officer | G-Gift | D | Common Stock | 1,640 | 0.00 | — | 65,021 | — | ↗ |
| 2024-06-18 | SPURLOCK GREGORY E. | Director | S-Sale | D | Common Stock | 7,167 | 59.75 | 428.2K | 2,591 | — | ↗ |
| 2024-06-18 | Patel Mital | Officer | S-Sale | D | Common Stock | 29,800 | 59.00 | 1.76M | 202,146 | — | ↗ |
| 2024-06-17 | SPURLOCK GREGORY E. | Director | S-Sale | D | Common Stock | 7,167 | 59.75 | 428.2K | 9,758 | — | ↗ |
| 2024-06-17 | Patel Mital | Officer | S-Sale | D | Common Stock | 10,200 | 60.00 | 612.0K | 231,946 | — | ↗ |
| 2024-06-14 | Levitt Lawrence L | Director | S-Sale | D | Common Stock | 4,000 | 57.77 | 231.1K | 172,657 | — | ↗ |
| 2024-06-13 | SWARTZ DAVID L | Director | A-Award | A | Common Stock | 2,591 | 0.00 | — | 199,067 | — | ↗ |
| 2024-06-13 | SPURLOCK GREGORY E. | Director | A-Award | A | Common Stock | 2,591 | 0.00 | — | 16,925 | — | ↗ |
| 2024-06-13 | Levitt Lawrence L | Director | A-Award | A | Common Stock | 2,591 | 0.00 | — | 176,657 | — | ↗ |
| 2024-06-13 | Jacobs Laura Pastre | Director | A-Award | A | Common Stock | 2,591 | 0.00 | — | 24,308 | — | ↗ |
| 2024-06-12 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 10,000 | 62.34 | 623.4K | 1,239,205 | — | ↗ |
| 2024-06-12 | SWARTZ DAVID L | Director | S-Sale | D | Common Stock | 4,066 | 62.42 | 253.8K | 196,476 | — | ↗ |
| 2024-06-12 | Murdock Michael N | Officer | S-Sale | D | Common Stock | 10,000 | 62.51 | 625.1K | 63,144 | — | ↗ |
| 2024-06-12 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 18,597 | 63.08 | 1.17M | 227,322 | — | ↗ |
| 2024-06-12 | Forthuber Stephen M | Officer | S-Sale | D | Common Stock | 40,000 | 62.33 | 2.49M | 523,561 | — | ↗ |
| 2024-06-11 | Sorensen Alma Gregory | Director / Officer | S-Sale | D | Common Stock | 5,000 | 61.24 | 306.2K | 1,249,205 | — | ↗ |
| 2024-06-11 | Patel Mital | Officer | G-Gift | D | Common Stock | 500 | 0.00 | — | 242,146 | — | ↗ |
| 2024-06-11 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 35,000 | 61.40 | 2.15M | 245,919 | — | ↗ |
| 2024-06-10 | SWARTZ DAVID L | Director | S-Sale | D | Common Stock | 20,934 | 60.43 | 1.27M | 200,542 | — | ↗ |
| 2024-06-10 | STOLPER MARK | Officer | S-Sale | D | Common Stock | 25,000 | 61.27 | 1.53M | 80,398 | — | ↗ |
| 2024-06-10 | Levitt Lawrence L | Director | S-Sale | D | Common Stock | 16,000 | 60.85 | 973.6K | 174,066 | — | ↗ |
| 2024-06-10 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 15,000 | 61.15 | 917.3K | 280,919 | — | ↗ |
| 2024-06-10 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 1,500 | 61.03 | 91.5K | 10,879 | — | ↗ |
| 2024-06-07 | Murdock Michael N | Officer | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 73,144 | — | ↗ |
| 2024-06-07 | Katz David Jeffrey | Officer | S-Sale | D | Common Stock | 16,400 | 61.26 | 1.00M | 65,441 | — | ↗ |
| 2024-06-07 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 3,000 | 61.30 | 183.9K | 12,379 | — | ↗ |
| 2024-03-01 | STOLPER MARK | Officer | A-Award | A | Employee Stock Option (right to buy) | 27,276 | 18.64 | 508.4K | 27,276 | — | ↗ |
| 2024-03-01 | Patel Mital | Officer | A-Award | A | Employee Stock Option (right to buy) | 29,891 | 18.64 | 557.2K | 29,891 | — | ↗ |
| 2024-03-01 | Katz David Jeffrey | Officer | A-Award | A | Employee Stock Option (right to buy) | 29,891 | 18.64 | 557.2K | 29,891 | — | ↗ |
| 2024-03-01 | HAMES NORMAN R | Officer | A-Award | A | Employee Stock Option (right to buy) | 33,789 | 18.64 | 629.8K | 33,789 | — | ↗ |
| 2024-03-01 | Forthuber Stephen M | Officer | A-Award | A | Employee Stock Option (right to buy) | 33,789 | 18.64 | 629.8K | 33,789 | — | ↗ |
| 2024-03-01 | BERGER HOWARD G | Director / Officer | A-Award | A | Common Stock | 40,236 | 0.00 | — | 40,236 | — | ↗ |
| 2024-01-09 | Sorenson Alma Gregory | Director / Officer | A-Award | A | Common Stock | 19,423 | 0.00 | — | 1,254,205 | — | ↗ |
| 2024-01-09 | STOLPER MARK | Officer | A-Award | A | Restricted Stock Units | 14,558 | 0.00 | — | 14,558 | — | ↗ |
| 2024-01-09 | Patel Mital | Officer | A-Award | A | Common Stock | 15,954 | 0.00 | — | 227,224 | — | ↗ |
| 2024-01-09 | Murdock Michael N | Officer | A-Award | A | Common Stock | 9,711 | 0.00 | — | 78,143 | — | ↗ |
| 2024-01-09 | Katz David Jeffrey | Officer | A-Award | A | Restricted Stock Units | 15,954 | 0.00 | — | 15,954 | — | ↗ |
| 2024-01-09 | Jayanathan Ranjan | Officer | A-Award | A | Common Stock | 16,648 | 0.00 | — | 229,215 | — | ↗ |
| 2024-01-09 | HAMES NORMAN R | Officer | A-Award | A | Restricted Stock Units | 18,036 | 0.00 | — | 18,036 | — | ↗ |
| 2024-01-09 | Gordon Christine Nayoma | Director | A-Award | A | Common Stock | 4,994 | 0.00 | — | 15,379 | — | ↗ |
| 2024-01-09 | Forthuber Stephen M | Officer | A-Award | A | Common Stock | 18,036 | 0.00 | — | 546,127 | — | ↗ |
| 2024-01-09 | BERGER HOWARD G | Director / Officer | A-Award | A | Restricted Stock Units | 55,494 | 0.00 | — | 55,494 | — | ↗ |
| 2024-01-04 | Patel Mital | Officer | M-Exempt | D | Restricted Stock Units | 1,221 | 0.00 | — | 1,220 | D | ↗ |
| 2024-01-04 | Katz David Jeffrey | Officer | M-Exempt | D | Restricted Stock Units | 1,220 | 0.00 | — | 1,221 | — | ↗ |
| 2024-01-04 | HAMES NORMAN R | Officer | M-Exempt | D | Restricted Stock Units | 1,380 | 0.00 | — | 1,380 | D | ↗ |
| 2024-01-04 | Forthuber Stephen M | Officer | M-Exempt | A | Common Stock | 1,380 | 0.00 | — | 552,622 | D | ↗ |
| 2023-12-06 | Levitt Lawrence L | Director | G-Gift | D | Common Stock | 5,700 | 0.00 | — | 190,066 | — | ↗ |
| 2023-12-05 | Murdock Michael N | Officer | S-Sale | D | Common Stock | 10,115 | 35.02 | 354.2K | 68,432 | — | ↗ |
| 2023-11-27 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 3,000 | 32.40 | 97.2K | 10,385 | — | ↗ |
| 2023-11-20 | Murdock Michael N | Officer | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 78,547 | — | ↗ |
| 2023-08-08 | Sorenson Alma Gregory | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,234,782 | — | ↗ |
| 2023-06-08 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 31.12 | 311.2K | 278,485 | — | ↗ |
| 2023-06-07 | SWARTZ DAVID L | Director | A-Award | A | Common Stock | 4,066 | 0.00 | — | 221,476 | — | ↗ |
| 2023-06-07 | SPURLOCK GREGORY E. | Director | A-Award | A | Common Stock | 4,066 | 0.00 | — | 14,334 | — | ↗ |
| 2023-06-07 | Levitt Lawrence L | Director | A-Award | A | Common Stock | 4,066 | 0.00 | — | 195,766 | — | ↗ |
| 2023-06-07 | Jacobs Laura Pastre | Director | A-Award | A | Common Stock | 4,066 | 0.00 | — | 21,717 | — | ↗ |
| 2023-06-07 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 15,000 | 30.92 | 463.8K | 288,485 | — | ↗ |
| 2023-06-06 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 20,000 | 31.11 | 622.2K | 303,485 | — | ↗ |
| 2023-06-02 | HAMES NORMAN R | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 19,179 | 6.30 | 120.8K | 0 | — | ↗ |
| 2023-05-23 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 4,884 | 28.34 | 138.4K | 13,385 | — | ↗ |
| 2023-05-19 | Patel Mital | Officer | G-Gift | D | Common Stock | 380 | 0.00 | — | 211,170 | — | ↗ |
| 2023-05-12 | STOLPER MARK | Officer | G-Gift | D | Common Stock | 900 | 0.00 | — | 91,326 | — | ↗ |
| 2023-05-04 | STOLPER MARK | Officer | G-Gift | D | Common Stock | 375 | 0.00 | — | 92,226 | — | ↗ |
| 2023-03-16 | Forthuber Stephen M | Officer | S-Sale | D | Common Stock | 10,000 | 23.02 | 230.2K | 528,091 | — | ↗ |
| 2023-03-03 | Villigerwilson Ruth Louisa | Director | S-Sale | D | Common Stock | 17,776 | 24.94 | 443.2K | 9,884 | — | ↗ |
| 2023-02-28 | STOLPER MARK | Officer | A-Award | A | Restricted Stock Units | 2,227 | 0.00 | — | 2,227 | — | ↗ |
| 2023-02-28 | Patel Mital | Officer | A-Award | A | Restricted Stock Units | 2,441 | 0.00 | — | 2,441 | — | ↗ |
| 2023-02-28 | Katz David Jeffrey | Officer | A-Award | A | Restricted Stock Units | 2,441 | 0.00 | — | 2,441 | — | ↗ |
| 2023-02-28 | HAMES NORMAN R | Officer | A-Award | A | Employee Stock Option (right to buy) | 6,013 | 29.44 | 177.0K | 6,013 | — | ↗ |
| 2023-02-28 | Forthuber Stephen M | Officer | A-Award | A | Restricted Stock Units | 2,760 | 0.00 | — | 2,760 | — | ↗ |
| 2023-01-03 | STOLPER MARK | Officer | A-Award | A | Employee Stock Option (right to buy) | 27,276 | 0.00 | — | 27,276 | — | ↗ |
| 2023-01-03 | Patel Mital | Officer | A-Award | A | Common Stock | 15,423 | 0.00 | — | 211,550 | — | ↗ |
| 2023-01-03 | Murdock Michael N | Officer | A-Award | A | Common Stock | 15,790 | 0.00 | — | 83,547 | — | ↗ |
| 2023-01-03 | Katz David Jeffrey | Officer | A-Award | A | Restricted Stock Units | 15,423 | 0.00 | — | 15,423 | — | ↗ |
| 2023-01-03 | Jayanathan Ranjan | Officer | A-Award | A | Common Stock | 26,316 | 0.00 | — | 212,567 | — | ↗ |
| 2023-01-03 | HAMES NORMAN R | Officer | A-Award | A | Restricted Stock Units | 17,435 | 0.00 | — | 17,435 | — | ↗ |
| 2023-01-03 | Gordon Christine Nayoma | Director | A-Award | A | Common Stock | 8,772 | 0.00 | — | 18,269 | — | ↗ |
| 2023-01-03 | Forthuber Stephen M | Officer | A-Award | A | Common Stock | 17,435 | 0.00 | — | 538,091 | — | ↗ |
| 2023-01-03 | BERGER HOWARD G | Officer | A-Award | A | Employee Stock Option (right to buy) | 103,969 | 0.00 | — | 103,969 | — | ↗ |
| 2022-12-19 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 5,000 | 19.45 | 97.2K | 275,179 | — | ↗ |
| 2022-12-19 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 3,000 | 19.57 | 58.7K | 9,497 | — | ↗ |
| 2022-12-08 | Levitt Lawrence L | Director | G-Gift | D | Common Stock | 9,300 | 0.00 | — | 191,700 | — | ↗ |
| 2022-06-08 | SWARTZ DAVID L | Director | A-Award | A | Common Stock | 6,269 | 0.00 | — | 237,410 | — | ↗ |
| 2022-06-08 | SPURLOCK GREGORY E. | Director | A-Award | A | Common Stock | 6,269 | 0.00 | — | 10,268 | — | ↗ |
| 2022-06-08 | Levitt Lawrence L | Director | A-Award | A | Common Stock | 6,269 | 0.00 | — | 201,000 | — | ↗ |
| 2022-06-08 | Jacobs Laura Pastre | Director | A-Award | A | Common Stock | 6,269 | 0.00 | — | 17,651 | — | ↗ |
| 2022-06-01 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 20.53 | 205.3K | 280,179 | — | ↗ |
| 2022-05-31 | Gordon Christine Nayoma | Director | S-Sale | D | Common Stock | 2,000 | 20.61 | 41.2K | 12,497 | — | ↗ |
| 2022-05-24 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 19.13 | 191.3K | 290,179 | — | ↗ |
| 2022-01-04 | Villigerwilson Ruth Louisa | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 27,660 | — | ↗ |
| 2022-01-04 | STOLPER MARK | Officer | A-Award | A | Restricted Stock Units | 4,882 | 0.00 | — | 4,882 | — | ↗ |
| 2022-01-04 | Patel Mital | Officer | A-Award | A | Employee stock option (right to buy) | 29,140 | 29.44 | 857.9K | 29,140 | — | ↗ |
| 2022-01-04 | Murdock Michael N | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 67,757 | — | ↗ |
| 2022-01-04 | Katz David Jeffrey | Officer | A-Award | A | Common Stock | 18,256 | 0.00 | — | 66,419 | — | ↗ |
| 2022-01-04 | Jayanathan Ranjan | Officer | A-Award | A | Restricted Stock Units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-01-04 | HAMES NORMAN R | Officer | A-Award | A | Employee stock option (right to buy) | 12,025 | 29.44 | 354.0K | 12,025 | — | ↗ |
| 2022-01-04 | Gordon Christine Nayoma | Director | A-Award | A | Common Stock | 6,897 | 0.00 | — | 15,397 | — | ↗ |
| 2022-01-04 | Forthuber Stephen M | Officer | A-Award | A | Employee stock option (right to buy) | 33,300 | 29.44 | 980.4K | 33,300 | — | ↗ |
| 2021-12-15 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 26.81 | 268.1K | 279,375 | — | ↗ |
| 2021-12-10 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 27.18 | 271.8K | 289,375 | — | ↗ |
| 2021-12-07 | Murdock Michael N | Officer | G-Gift | D | Common Stock | 10,000 | 0.00 | — | 57,757 | — | ↗ |
| 2021-12-03 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 10,000 | 27.66 | 276.6K | 299,375 | — | ↗ |
| 2021-12-01 | Levitt Lawrence L | Director | G-Gift | D | Common Stock | 6,750 | 0.00 | — | 194,731 | — | ↗ |
| 2021-11-15 | HAMES NORMAN R | Officer | M-Exempt | D | Stock Option (right to buy) | 16,772 | 0.00 | — | 8,386 | — | ↗ |
| 2021-10-01 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 17,528 | 28.29 | 495.9K | 285,387 | — | ↗ |
| 2021-09-21 | Villigerwilson Ruth Louisa | Officer | A-Award | A | Common Stock | 746 | 0.00 | — | 17,660 | — | ↗ |
| 2021-09-21 | STOLPER MARK | Officer | A-Award | A | Restricted Stock Units | 2,410 | 0.00 | — | 2,410 | — | ↗ |
| 2021-09-21 | Patel Mital | Officer | A-Award | A | Common Stock | 2,296 | 0.00 | — | 177,871 | — | ↗ |
| 2021-09-21 | Murdock Michael N | Officer | A-Award | A | Common Stock | 1,837 | 0.00 | — | 67,757 | — | ↗ |
| 2021-09-21 | Katz David Jeffrey | Officer | A-Award | A | Common Stock | 1,994 | 0.00 | — | 48,163 | — | ↗ |
| 2021-09-21 | Jayanathan Ranjan | Officer | A-Award | A | Restricted Stock Units | 2,066 | 0.00 | — | 2,066 | — | ↗ |
| 2021-09-21 | HAMES NORMAN R | Officer | A-Award | A | Common Stock | 2,755 | 0.00 | — | 302,915 | — | ↗ |
| 2021-09-21 | Forthuber Stephen M | Officer | A-Award | A | Common Stock | 2,755 | 0.00 | — | 499,852 | — | ↗ |
| 2021-09-02 | Villigerwilson Ruth Louisa | Director / Officer | S-Sale | D | Common Stock | 3,246 | 31.47 | 102.2K | 16,914 | — | ↗ |
| 2021-08-11 | SWARTZ DAVID L | Director | P-Purchase | A | Common Stock | 4,519 | 33.47 | 151.3K | 4,519 | — | ↗ |
| 2021-07-01 | HAMES NORMAN R | Officer | S-Sale | D | Common Stock | 35,000 | 33.66 | 1.18M | 300,160 | — | ↗ |
| 2021-06-10 | Villigerwilson Ruth Louisa | Officer | S-Sale | D | Common Stock | 15,000 | 31.51 | 472.7K | 20,160 | — | ↗ |
Executive team
Top executives
EBIT / Employee
8.3K
Shares Outstanding
78.27M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 3.00M | — | 9.00M | — | — | 88.0K | 12.09M | 74.45% | ↗ |
| 2 | 2025 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 800.0K | 400.0K | 2.00M | — | — | 54.5K | 3.25M | 61.45% | ↗ |
| 3 | 2025 | Norman R. Hames President and Chief Operating Officer - Western Operations | 800.0K | 400.0K | 2.00M | — | — | 38.1K | 3.24M | 61.76% | ↗ |
| 4 | 2025 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 750.0K | 375.0K | 1.87M | — | — | 55.6K | 3.06M | 61.36% | ↗ |
| 5 | 2025 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 700.0K | 350.0K | 1.75M | — | — | 33.5K | 2.83M | 61.76% | ↗ |
| 6 | 2024 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 3.00M | 4.00M | 2.00M | — | — | 76.4K | 9.08M | 22.04% | ↗ |
| 7 | 2024 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 3.00M | 4.00M | 2.00M | — | — | 76.4K | 9.08M | 22.04% | ↗ |
| 8 | 2024 | Cornelis Wesdorp President and Chief Executive Officer of Digital Health | 153.3K | — | 4.16M | — | — | 13.6K | 4.33M | 96.14% | ↗ |
| 9 | 2024 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 800.0K | 650.0K | 650.0K | — | — | 52.9K | 2.15M | 30.19% | ↗ |
| 10 | 2024 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 800.0K | 650.0K | 650.0K | — | — | 52.9K | 2.15M | 30.19% | ↗ |
| 11 | 2024 | Norman R. Hames President and Chief Operating Officer - Western Operations | 800.0K | 650.0K | 650.0K | — | — | 36.5K | 2.14M | 30.42% | ↗ |
| 12 | 2024 | Norman R. Hames President and Chief Operating Officer - Western Operations | 800.0K | 650.0K | 650.0K | — | — | 36.5K | 2.14M | 30.42% | ↗ |
| 13 | 2024 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 750.0K | 575.0K | 575.0K | — | — | 56.0K | 1.96M | 29.40% | ↗ |
| 14 | 2024 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 700.0K | 575.0K | 575.0K | — | — | 33.2K | 1.88M | 30.53% | ↗ |
| 15 | 2024 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 700.0K | 575.0K | 575.0K | — | — | 33.2K | 1.88M | 30.53% | ↗ |
| 16 | 2023 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.50M | 2.00M | 1.38M | 1.75M | — | 75.2K | 6.70M | 46.64% | ↗ |
| 17 | 2023 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.50M | 2.00M | 1.38M | 1.75M | — | 75.2K | 6.70M | 46.64% | ↗ |
| 18 | 2023 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 650.0K | 325.0K | 487.5K | 650.0K | — | 48.1K | 2.16M | 52.65% | ↗ |
| 19 | 2023 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 650.0K | 325.0K | 487.5K | 650.0K | — | 48.1K | 2.16M | 52.65% | ↗ |
| 20 | 2023 | Norman R. Hames President and Chief Operating Officer - Western Operations | 650.0K | 325.0K | 487.5K | 650.0K | — | 30.5K | 2.14M | 53.08% | ↗ |
| 21 | 2023 | Norman R. Hames President and Chief Operating Officer - Western Operations | 650.0K | 325.0K | 487.5K | 650.0K | — | 30.5K | 2.14M | 53.08% | ↗ |
| 22 | 2023 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 575.0K | 287.5K | 431.3K | 575.0K | — | 49.4K | 1.92M | 52.46% | ↗ |
| 23 | 2023 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 575.0K | 287.5K | 431.3K | 575.0K | — | 49.4K | 1.92M | 52.46% | ↗ |
| 24 | 2023 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 575.0K | 287.5K | 431.3K | 575.0K | — | 32.0K | 1.90M | 52.94% | ↗ |
| 25 | 2023 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 575.0K | 287.5K | 431.3K | 575.0K | — | 32.0K | 1.90M | 52.94% | ↗ |
| 26 | 2022 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.50M | 4.00M | — | — | — | 55.5K | 5.56M | 0.00% | ↗ |
| 27 | 2022 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 650.0K | 600.0K | 775.0K | 937.5K | — | 47.3K | 3.01M | 56.90% | ↗ |
| 28 | 2022 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 650.0K | 600.0K | 775.0K | 937.5K | — | 47.3K | 3.01M | 56.90% | ↗ |
| 29 | 2022 | Norman R. Hames President and Chief Operating Officer - Western Operations | 650.0K | 600.0K | 775.0K | 937.5K | — | 26.8K | 2.99M | 57.29% | ↗ |
| 30 | 2022 | Norman R. Hames President and Chief Operating Officer – Western Operations | 650.0K | 600.0K | 775.0K | 937.5K | — | 26.8K | 2.99M | 57.29% | ↗ |
| 31 | 2022 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 575.0K | 525.0K | 681.3K | 825.0K | — | 50.8K | 2.66M | 56.69% | ↗ |
| 32 | 2022 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 575.0K | 525.0K | 681.3K | 825.0K | — | 31.2K | 2.64M | 57.11% | ↗ |
| 33 | 2021 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.20M | 3.31M | — | — | — | 58.6K | 4.57M | 0.00% | ↗ |
| 34 | 2021 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 524.0K | 375.0K | 1.15M | — | — | 38.9K | 2.09M | 55.16% | ↗ |
| 35 | 2021 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 600.0K | 450.0K | 526.7K | — | — | 37.3K | 1.61M | 32.63% | ↗ |
| 36 | 2021 | Stephen M. Forthuber President and Chief Operating Officer - Eastern Operations | 600.0K | 450.0K | 526.7K | — | — | 37.3K | 1.61M | 32.63% | ↗ |
| 37 | 2021 | Norman R. Hames President and Chief Operating Officer - Western Operations | 600.0K | 450.0K | 526.7K | — | — | 16.4K | 1.59M | 33.06% | ↗ |
| 38 | 2021 | Norman R. Hames President and Chief Operating Officer – Western Operations | 600.0K | 450.0K | 526.7K | — | — | 16.4K | 1.59M | 33.06% | ↗ |
| 39 | 2021 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 525.0K | 393.8K | 460.9K | — | — | 28.5K | 1.41M | 32.73% | ↗ |
| 40 | 2020 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 782.7K | 2.00M | — | — | — | 53.1K | 2.84M | 0.00% | ↗ |
| 41 | 2020 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 445.2K | 275.0K | 275.0K | 124.3K | — | 31.4K | 1.15M | 34.69% | ↗ |
| 42 | 2020 | Norman R. Hames President and Chief Operating Officer – Western Operations | 445.2K | 275.0K | 275.0K | 124.3K | — | 12.6K | 1.13M | 35.27% | ↗ |
| 43 | 2020 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 389.4K | 237.5K | 237.5K | 107.3K | — | 24.0K | 995.7K | 34.63% | ↗ |
| 44 | 2020 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 368.2K | 212.5K | 212.5K | 96.0K | — | 33.2K | 922.4K | 33.45% | ↗ |
| 45 | 2019 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.00M | 2.00M | — | — | — | 48.4K | 3.05M | 0.00% | ↗ |
| 46 | 2019 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 550.0K | 275.0K | 275.0K | 131.8K | — | 33.4K | 1.27M | 32.15% | ↗ |
| 47 | 2019 | Norman R. Hames President and Chief Operating Officer – Western Operations | 550.0K | 275.0K | 275.0K | 131.8K | — | 14.9K | 1.25M | 32.63% | ↗ |
| 48 | 2019 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 237.5K | 237.5K | 113.9K | — | 25.6K | 1.09M | 32.25% | ↗ |
| 49 | 2019 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 425.0K | 187.5K | 187.5K | 89.9K | — | 34.0K | 924.0K | 30.02% | ↗ |
| 50 | 2019 | Mital Patel Executive Vice President of Financial Planning and Analysis | 425.0K | 187.5K | 187.5K | 89.9K | — | 34.0K | 924.0K | 30.02% | ↗ |
| 51 | 2018 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 1.00M | 2.00M | — | — | — | 11.9K | 3.01M | 0.00% | ↗ |
| 52 | 2018 | Jeffrey L. Linden, Former Executive Vice President and General Counsel | 454.3K | 262.5K | 262.5K | 137.7K | — | 678.5K | 1.80M | 22.29% | ↗ |
| 53 | 2018 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 550.0K | 275.0K | 275.0K | 144.3K | — | 17.8K | 1.26M | 33.22% | ↗ |
| 54 | 2018 | Norman R. Hames President and Chief Operating Officer – Western Operations | 550.0K | 275.0K | 275.0K | 144.3K | — | 7.6K | 1.25M | 33.49% | ↗ |
| 55 | 2018 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 237.5K | 237.5K | 124.6K | — | 31.8K | 1.11M | 32.73% | ↗ |
| 56 | 2018 | Mital Patel Executive Vice President of Financial Planning and Analysis | 375.0K | 187.5K | 187.5K | 98.4K | — | 20.0K | 868.4K | 32.92% | ↗ |
| 57 | 2018 | Mital Patel Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer | 375.0K | 187.5K | 187.5K | 98.4K | — | 20.0K | 868.4K | 32.92% | ↗ |
| 58 | 2017 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 700.0K | 1.20M | — | — | — | 10.6K | 1.91M | 0.00% | ↗ |
| 59 | 2017 | Jeffrey L. Linden, Former Executive Vice President and General Counsel | 525.0K | 262.5K | 262.5K | 143.2K | — | 23.5K | 1.22M | 33.35% | ↗ |
| 60 | 2017 | Jeffrey L. Linden, Executive Vice President and General Counsel | 525.0K | 262.5K | 262.5K | 143.2K | — | 23.5K | 1.22M | 33.35% | ↗ |
| 61 | 2017 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 550.0K | 237.5K | 237.5K | 129.6K | — | 27.1K | 1.18M | 31.07% | ↗ |
| 62 | 2017 | Norman R. Hames President and Chief Operating Officer – Western Operations | 550.0K | 237.5K | 237.5K | 129.6K | — | 16.0K | 1.17M | 31.36% | ↗ |
| 63 | 2017 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 237.5K | 237.5K | 129.6K | — | 26.7K | 1.11M | 33.18% | ↗ |
| 64 | 2016 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 700.0K | 1.00M | — | — | — | 26.5K | 1.73M | 0.00% | ↗ |
| 65 | 2016 | Jeffrey L. Linden, Former Executive Vice President and General Counsel | 525.0K | 262.5K | 262.5K | 152.4K | — | 20.8K | 1.23M | 33.64% | ↗ |
| 66 | 2016 | Jeffrey L. Linden, Executive Vice President and General Counsel | 525.0K | 262.5K | 262.5K | 152.4K | — | 20.8K | 1.23M | 33.64% | ↗ |
| 67 | 2016 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 475.0K | 237.5K | 237.5K | 237.5K | — | 27.4K | 1.21M | 39.10% | ↗ |
| 68 | 2016 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 475.0K | 237.5K | 237.5K | 237.5K | — | 14.2K | 1.20M | 39.53% | ↗ |
| 69 | 2016 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 475.0K | 237.5K | 237.5K | 137.9K | — | 27.4K | 1.12M | 33.66% | ↗ |
| 70 | 2016 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 237.5K | 237.5K | 137.9K | — | 24.0K | 1.11M | 33.76% | ↗ |
| 71 | 2016 | Norman R. Hames President and Chief Operating Officer – Western Operations | 475.0K | 237.5K | 237.5K | 137.9K | — | 14.2K | 1.10M | 34.06% | ↗ |
| 72 | 2015 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 707.7K | 1.00M | — | — | — | 11.5K | 1.72M | 0.00% | ↗ |
| 73 | 2015 | Jeffrey L. Linden, Executive Vice President and General Counsel | 545.2K | 262.5K | 262.5K | — | — | 21.1K | 1.09M | 24.05% | ↗ |
| 74 | 2015 | Stephen M. Forthuber President and Chief Operating Officer – Eastern Operations | 493.3K | 237.5K | 237.5K | — | — | 24.9K | 993.1K | 23.91% | ↗ |
| 75 | 2015 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 493.3K | 237.5K | 237.5K | — | — | 24.9K | 993.1K | 23.91% | ↗ |
| 76 | 2015 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 493.3K | 237.5K | 237.5K | — | — | 24.4K | 992.6K | 23.93% | ↗ |
| 77 | 2015 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 479.3K | 237.5K | 237.5K | — | — | 13.6K | 967.9K | 24.54% | ↗ |
| 78 | 2015 | Norman R. Hames President and Chief Operating Officer – Western Operations | 479.3K | 237.5K | 237.5K | — | — | 13.6K | 967.9K | 24.54% | ↗ |
| 79 | 2014 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 700.0K | 375.0K | — | — | — | 16.6K | 1.09M | 0.00% | ↗ |
| 80 | 2014 | Jeffrey L. Linden, Executive Vice President and General Counsel | 525.0K | 131.3K | 137.5K | — | — | 26.2K | 820.0K | 16.77% | ↗ |
| 81 | 2014 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 475.0K | 118.8K | 125.0K | — | — | 25.6K | 744.3K | 16.79% | ↗ |
| 82 | 2014 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 475.0K | 118.8K | 125.0K | — | — | 15.4K | 734.2K | 17.03% | ↗ |
| 83 | 2014 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | — | 125.0K | — | — | 25.3K | 625.3K | 19.99% | ↗ |
| 84 | 2013 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 700.0K | 375.0K | — | — | — | 16.6K | 1.09M | 0.00% | ↗ |
| 85 | 2013 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 700.0K | 375.0K | — | — | — | 16.6K | 1.09M | 0.00% | ↗ |
| 86 | 2013 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 237.5K | 125.5K | — | — | 24.0K | 862.0K | 14.56% | ↗ |
| 87 | 2013 | Jeffrey L. Linden, Executive Vice President and General Counsel | 525.0K | 131.3K | 138.1K | — | — | 26.2K | 820.5K | 16.82% | ↗ |
| 88 | 2013 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 475.0K | 118.8K | 125.5K | — | — | 60.0K | 779.3K | 16.11% | ↗ |
| 89 | 2013 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 118.8K | 125.5K | — | — | 24.0K | 742.2K | 16.91% | ↗ |
| 90 | 2013 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 475.0K | 118.8K | 125.5K | — | — | 4.9K | 724.1K | 17.33% | ↗ |
| 91 | 2012 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 700.0K | 375.0K | — | — | — | 12.2K | 1.09M | 0.00% | ↗ |
| 92 | 2012 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 700.0K | 375.0K | — | — | — | 12.2K | 1.09M | 0.00% | ↗ |
| 93 | 2012 | Jeffrey L. Linden, Executive Vice President and General Counsel | 525.0K | 131.3K | 162.8K | — | — | 21.8K | 840.8K | 19.36% | ↗ |
| 94 | 2012 | Jeffrey L. Linden Executive Vice President and General Counsel | 525.0K | 131.3K | 162.8K | — | — | 21.8K | 840.8K | 19.36% | ↗ |
| 95 | 2012 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 118.8K | 162.8K | — | — | 29.6K | 786.1K | 20.70% | ↗ |
| 96 | 2012 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 475.0K | 118.8K | 162.8K | — | — | 29.6K | 786.1K | 20.70% | ↗ |
| 97 | 2012 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 475.0K | 118.8K | 162.8K | — | — | 4.9K | 761.4K | 21.38% | ↗ |
| 98 | 2012 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 475.0K | 118.8K | 162.8K | — | — | 4.9K | 761.4K | 21.38% | ↗ |
| 99 | 2012 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 475.0K | 118.8K | 162.8K | — | — | — | 756.5K | 21.51% | ↗ |
| 100 | 2012 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 475.0K | 118.8K | 162.8K | — | — | — | 756.5K | 21.51% | ↗ |
| 101 | 2011 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 625.0K | — | — | — | — | 15.3K | 640.3K | 0.00% | ↗ |
| 102 | 2011 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 625.0K | — | — | — | — | 15.3K | 640.3K | 0.00% | ↗ |
| 103 | 2011 | Jeffrey L. Linden Executive Vice President and General Counsel | 475.0K | — | — | 137.0K | — | 19.7K | 631.7K | 21.69% | ↗ |
| 104 | 2011 | Jeffrey L. Linden, Executive Vice President and General Counsel | 475.0K | — | — | 137.0K | — | 19.7K | 631.7K | 21.69% | ↗ |
| 105 | 2011 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 425.0K | 50.0K | — | 137.0K | — | 4.9K | 616.9K | 22.21% | ↗ |
| 106 | 2011 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 425.0K | 50.0K | — | 137.0K | — | 4.9K | 616.9K | 22.21% | ↗ |
| 107 | 2011 | Norman R. Hames, Executive Vice President and Chief Operating Officer – Western Operations | 425.0K | 50.0K | — | 137.0K | — | 4.9K | 616.9K | 22.21% | ↗ |
| 108 | 2011 | Stephen M. Forthuber, Executive Vice President and Chief Operating Officer – Eastern Operations | 425.0K | — | — | 182.6K | — | — | 607.6K | 30.06% | ↗ |
| 109 | 2011 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 425.0K | — | — | 182.6K | — | — | 607.6K | 30.06% | ↗ |
| 110 | 2011 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 425.0K | — | — | 182.6K | — | — | 607.6K | 30.06% | ↗ |
| 111 | 2011 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 425.0K | — | — | 137.0K | — | 36.8K | 598.8K | 22.88% | ↗ |
| 112 | 2011 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 425.0K | — | — | 137.0K | — | 36.8K | 598.8K | 22.88% | ↗ |
| 113 | 2010 | Howard G. Berger, M.D. President and Chief Executive Officer (principal executive officer) | 625.0K | — | — | — | — | 9.8K | 634.8K | 0.00% | ↗ |
| 114 | 2010 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 625.0K | — | — | — | — | 9.8K | 634.8K | 0.00% | ↗ |
| 115 | 2010 | Jeffrey L. Linden Executive Vice President and General Counsel | 400.0K | — | — | 159.6K | — | 16.7K | 576.3K | 27.70% | ↗ |
| 116 | 2010 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | 159.6K | — | 16.7K | 576.3K | 27.70% | ↗ |
| 117 | 2010 | John V. Crues, III, M.D., Vice President and Medical Director | 549.9K | — | — | — | — | 6.0K | 555.9K | 0.00% | ↗ |
| 118 | 2010 | Mark D. Stolper Executive Vice President and Chief Financial Officer (principal financial officer) | 350.0K | — | — | 159.6K | — | 8.0K | 517.6K | 30.84% | ↗ |
| 119 | 2010 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 350.0K | — | — | 159.6K | — | 8.0K | 517.6K | 30.84% | ↗ |
| 120 | 2010 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 159.6K | — | 4.9K | 514.5K | 31.03% | ↗ |
| 121 | 2010 | Norman R. Hames, Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 159.6K | — | 4.9K | 514.5K | 31.03% | ↗ |
| 122 | 2010 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 159.6K | — | 4.9K | 514.5K | 31.03% | ↗ |
| 123 | 2010 | Stephen M. Forthuber Executive Vice President and Chief Operating Officer – Eastern Operations | 350.0K | — | — | 159.6K | — | — | 509.6K | 31.32% | ↗ |
| 124 | 2010 | Stephen M. Forthuber, Executive Vice President and Chief Operating Officer – Eastern Operations | 350.0K | — | — | 159.6K | — | — | 509.6K | 31.32% | ↗ |
| 125 | 2009 | Stephen M. Forthuber, Executive Vice President and Chief Operating Officer – Eastern Operations | 350.0K | 250.0K | — | 488.0K | — | — | 1.09M | 44.85% | ↗ |
| 126 | 2009 | John V. Crues, III, M.D., Vice President and Medical Director | 590.6K | — | — | 146.5K | — | 6.0K | 743.1K | 19.72% | ↗ |
| 127 | 2009 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 350.0K | — | — | 366.3K | — | 7.1K | 723.4K | 50.64% | ↗ |
| 128 | 2009 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 350.0K | — | — | 366.3K | — | — | 716.3K | 51.14% | ↗ |
| 129 | 2009 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | 219.8K | — | 15.7K | 635.4K | 34.59% | ↗ |
| 130 | 2009 | Norman R. Hames, Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 219.8K | — | 4.9K | 574.6K | 38.24% | ↗ |
| 131 | 2009 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 219.8K | — | 4.9K | 574.6K | 38.24% | ↗ |
| 132 | 2009 | Howard G. Berger, M.D., Principal Executive Officer | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 133 | 2009 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 134 | 2008 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 350.0K | — | — | 540.9K | — | 4.9K | 895.7K | 60.38% | ↗ |
| 135 | 2008 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | 240.9K | — | 15.4K | 656.2K | 36.70% | ↗ |
| 136 | 2008 | Mark D. Stolper, Executive Vice President and Chief Financial Officer (principal financial officer) | 348.8K | — | — | 240.9K | — | 6.8K | 596.5K | 40.38% | ↗ |
| 137 | 2008 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 348.8K | — | — | 240.9K | — | — | 589.7K | 40.84% | ↗ |
| 138 | 2008 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 354.0K | — | — | 93.7K | — | — | 576.7K | 16.24% | ↗ |
| 139 | 2008 | John V. Crues, III, M.D., Vice President and Medical Director | 512.8K | — | — | — | — | 6.0K | 518.8K | 0.00% | ↗ |
| 140 | 2008 | John V. Crues, III, M.D., Medical Director | 512.8K | — | — | — | — | — | 512.8K | 0.00% | ↗ |
| 141 | 2008 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | 93.6K | — | — | 503.3K | 18.59% | ↗ |
| 142 | 2008 | Howard G. Berger, M.D., Principal Executive Officer | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 143 | 2008 | Howard G. Berger, M.D., Principal Executive Officer | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 144 | 2008 | Howard G. Berger, M.D., President and Chief Executive Officer (principal executive officer) | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 145 | 2008 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 348.8K | — | — | 93.7K | — | — | 442.5K | 21.17% | ↗ |
| 146 | 2007 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 303.3K | — | — | 1.21M | — | — | 1.52M | 80.01% | ↗ |
| 147 | 2007 | John V. Crues, III, M.D., Vice President and Medical Director | 558.0K | — | — | — | — | — | 558.0K | 0.00% | ↗ |
| 148 | 2007 | John V. Crues, III, M.D., Medical Director | 558.0K | — | — | — | — | — | 558.0K | 0.00% | ↗ |
| 149 | 2007 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 300.0K | — | — | 205.7K | — | — | 455.7K | 45.14% | ↗ |
| 150 | 2007 | Howard G. Berger, M.D., Principal Executive Officer | 415.0K | — | — | — | — | — | 415.0K | 0.00% | ↗ |
| 151 | 2007 | Howard G. Berger, M.D., Principal Executive Officer | 415.0K | — | — | — | — | — | 415.0K | 0.00% | ↗ |
| 152 | 2007 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | — | — | — | 400.0K | 0.00% | ↗ |
| 153 | 2007 | Jeffrey L. Linden, Executive Vice President and General Counsel | 400.0K | — | — | — | — | — | 400.0K | 0.00% | ↗ |
| 154 | 2007 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 303.3K | — | — | — | — | — | 303.3K | 0.00% | ↗ |
| 155 | 2007 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 300.0K | — | — | — | — | — | 300.0K | 0.00% | ↗ |
| 156 | 2006 | Jeffrey L. Linden, Executive Vice President and General Counsel | 350.0K | — | — | 472.4K | — | — | 822.4K | 57.44% | ↗ |
| 157 | 2006 | John V. Crues, III, M.D., Medical Director | 453.0K | — | — | — | — | — | 450.0K | 0.00% | ↗ |
| 158 | 2006 | Norman R. Hames Executive Vice President and Chief Operating Officer – Western Operations | 224.5K | 129.0K | — | 137.9K | — | — | 362.5K | 38.06% | ↗ |
| 159 | 2006 | Mark D. Stolper, Executive Vice President and Principal Financial Officer | 250.0K | — | — | 124.9K | — | — | 250.0K | 49.96% | ↗ |
| 160 | 2006 | Howard G. Berger, M.D., Principal Executive Officer | 50.0K | — | — | — | — | — | 50.0K | 0.00% | ↗ |
| 161 | 2005 | John V. Crues, III, M.D., Vice President | 440.0K | — | — | — | — | — | 440.0K | 0.00% | ↗ |
| 162 | 2005 | Jeffrey L. Linden, Vice President and General Counsel | 350.0K | — | — | — | — | — | 350.0K | 0.00% | ↗ |
| 163 | 2005 | Mark D. Stolper Chief Financial Officer | 223.8K | — | — | — | — | — | 223.8K | 0.00% | ↗ |
| 164 | 2005 | Norman R. Hames, Vice President, Secretary and Chief Operating Officer | 220.0K | — | — | — | — | — | 220.0K | 0.00% | ↗ |
| 165 | 2005 | Howard G. Berger, M.D., Chief Executive Officer and President | 200.0K | — | — | — | — | — | 200.0K | 0.00% | ↗ |
| 166 | 2004 | John V. Crues, III, M.D., Vice President | 370.0K | — | — | 500.0K | — | — | 370.0K | 135.14% | ↗ |
| 167 | 2004 | Jeffrey L. Linden, Vice President and General Counsel | 350.0K | — | — | 200.0K | — | — | 350.0K | 57.14% | ↗ |
| 168 | 2004 | Norman R. Hames, Vice President, Secretary and Chief Operating Officer | 229.0K | — | — | — | — | — | 229.0K | 0.00% | ↗ |
| 169 | 2004 | Howard G. Berger, M.D., Chief Executive Officer and President | 225.0K | — | — | — | — | — | 225.0K | 0.00% | ↗ |
| 170 | 2004 | Mark D. Stolper Chief Financial Officer | 53.8K | — | — | 700.0K | — | — | 53.8K | 1,301.60% | ↗ |
| 171 | 2003 | John V. Crues, III, M.D., Vice President | 363.0K | — | — | — | — | — | 363.0K | 0.00% | ↗ |
| 172 | 2003 | Howard G. Berger, M.D., Chief Executive Officer and President | 328.8K | — | — | — | — | — | 328.8K | 0.00% | ↗ |
| 173 | 2003 | Jeffrey L. Linden, Vice President and General Counsel | 303.0K | — | — | — | — | — | 303.0K | 0.00% | ↗ |
| 174 | 2003 | Norman R. Hames, Vice President, Secretary and Chief Operating Officer | 225.0K | — | — | — | — | — | 225.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Howard G. Berger | Chairman, President & Chief Executive Officer | 3M | — |
| Stephen Forthuber | President & CEO of Eastern Operations | 1M | male |
| Norman R. Hames | President & CEO of Western Operations | 1M | male |
| Mital Patel | Executive VP & COO | 1M | male |
| Mark D. Stolper | Executive Vice President & Chief Financial Officer | 1M | male |
| A. Gregory Sorensen | Executive VP, Chief Strategy Officer & Director | 629.1K | — |
| Cornelis Wesdorp | President & Chief Executive Officer of Digital Health | 627.0K | male |
| Michael Murdock | Executive Vice President of Mergers & Acquisitions | — | male |
| Laura Foster BSRT | Senior Vice President of Compliance & Regulatory Affairs | — | female |
| David Jeffrey Katz | Executive Vice President, Chief Legal Officer & Corporate Secretary | — | male |
| Susan Hollabaugh | Chief Information Officer | — | female |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RDNT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
